Bloomberg BNA's Pharmaceutical Law & Industry Report helps you stay informed of regulatory and litigation developments affecting the pharmaceutical and biotech industries....
Feb. 12 — The FDA will hold a public workshop in April to discuss a proposed pilot program to enhance the safety and security of the pharmaceutical distribution supply chain, according to a notice to be published Feb. 16 in the Federal Register.
The Food and Drug Administration is required under the Drug Supply Chain Security Act (DSCSA) of 2013 (Pub. L. No. 113-54) to establish one or more pilot projects, in coordination with authorized drug manufacturers, repackagers, wholesale distributors and dispensers, “to explore and evaluate methods to enhance the safety and security of the pharmaceutical distribution supply chain,” the agency said. The DSCSA establishes a federal system for tracing prescription drug products.
The FDA said the public workshop is intended to let those who are interested provide comments on and discuss design objectives of the pilot projects. The agency said it would like to get comments from interested pharmaceutical distribution supply chain members on:
The public workshop will be held April 5 from 9 a.m. to 5 p.m. and April 6 from 9 a.m. to 12:15 p.m. at the FDA's White Oak campus in Silver Spring, Md. To register for the workshop, go to http://www.fda.gov/Drugs/NewsEvents/ucm481767.htm. Registration requests must be received by March 11.
The deadline for submitting either electronic or written comments on this workshop is April 21 (Docket No. FDA-2016-N-0407).
To contact the reporter on this story: Bronwyn Mixter in Washington at email@example.com
To contact the editor responsible for this story: Lee Barnes at firstname.lastname@example.org
The Federal Register notice is at http://src.bna.com/cCy.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to email@example.com.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to firstname.lastname@example.org.
Put me on standing order
Notify me when new releases are available (no standing order will be created)